GFAP and Alzheimer disease: Similar to the other two panels (age+sex+APOE4+GFAP panel and age+sex+APOE4+NfL panel), the combination panel could not improve the distinction between MCI vs. AD (AUC 72.3%, 95%CI = 0.63–0.82, Figure 3C).